These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38038134)

  • 1. High-frequency home self-collection of capillary blood correlates IFI27 expression kinetics with SARS-CoV-2 viral clearance.
    Lim FY; Kim SY; Kulkarni KN; Blazevic RL; Kimball LE; Lea HG; Haack AJ; Gower MS; Stevens-Ayers T; Starita LM; Boeckh M; Hyrien O; Schiffer JT; Theberge AB; Waghmare A
    J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 38038134
    [No Abstract]   [Full Text] [Related]  

  • 2. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
    Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal home self-collection of capillary blood using
    Lim FY; Kim SY; Kulkarni KN; Blazevic RL; Kimball LE; Lea HG; Haack AJ; Gower MS; Stevens-Ayers T; Starita LM; Boeckh M; Schiffer JT; Hyrien O; Theberge AB; Waghmare A
    medRxiv; 2023 Jan; ():. PubMed ID: 37034678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-collection of capillary blood using Tasso-SST devices for Anti-SARS-CoV-2 IgG antibody testing.
    Hendelman T; Chaudhary A; LeClair AC; van Leuven K; Chee J; Fink SL; Welch EJ; Berthier E; Quist BA; Wald A; Wener MH; Hoofnagle AN; Morishima C
    PLoS One; 2021; 16(9):e0255841. PubMed ID: 34473717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.
    Li L; Liang Y; Hu F; Yan H; Li Y; Xie Z; Huang L; Zhao J; Wan Z; Wang H; Shui J; Cai W; Tang S
    Virology; 2020 Dec; 551():26-35. PubMed ID: 33011520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates.
    Mollan KR; Eron JJ; Krajewski TJ; Painter W; Duke ER; Morse CG; Goecker EA; Premkumar L; Wolfe CR; Szewczyk LJ; Alabanza PL; Loftis AJ; Degli-Angeli EJ; Brown AJ; Dragavon JA; Won JJ; Keys J; Hudgens MG; Fang L; Wohl DA; Cohen MS; Baric RS; Coombs RW; Sheahan TP; Fischer WA
    Clin Infect Dis; 2022 Aug; 75(1):e1028-e1036. PubMed ID: 35022711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study.
    Hay JA; Kissler SM; Fauver JR; Mack C; Tai CG; Samant RM; Connolly S; Anderson DJ; Khullar G; MacKay M; Patel M; Kelly S; Manhertz A; Eiter I; Salgado D; Baker T; Howard B; Dudley JT; Mason CE; Nair M; Huang Y; DiFiori J; Ho DD; Grubaugh ND; Grad YH
    Elife; 2022 Nov; 11():. PubMed ID: 36383192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.
    Carsetti R; Zaffina S; Piano Mortari E; Terreri S; Corrente F; Capponi C; Palomba P; Mirabella M; Cascioli S; Palange P; Cuccaro I; Milito C; Zumla A; Maeurer M; Camisa V; Vinci MR; Santoro A; Cimini E; Marchioni L; Nicastri E; Palmieri F; Agrati C; Ippolito G; Porzio O; Concato C; Onetti Muda A; Raponi M; Quintarelli C; Quinti I; Locatelli F
    Front Immunol; 2020; 11():610300. PubMed ID: 33391280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies.
    Wong MP; Meas MA; Adams C; Hernandez S; Green V; Montoya M; Hirsch BM; Horton M; Quach HL; Quach DL; Shao X; Fedrigo I; Zermeno A; Huffaker J; Montes R; Madden A; Cyrus S; McDowell D; Williamson P; Contestable P; Stone M; Coloma J; Busch MP; Barcellos LF; Harris E
    Microbiol Spectr; 2022 Jun; 10(3):e0247121. PubMed ID: 35612315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of Viral Clearance and Antibody Production Across Age Groups in Children with Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Bahar B; Jacquot C; Mo YD; DeBiasi RL; Campos J; Delaney M
    J Pediatr; 2020 Dec; 227():31-37.e1. PubMed ID: 32891640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of viral load and antibody response in relation to COVID-19 severity.
    Wang Y; Zhang L; Sang L; Ye F; Ruan S; Zhong B; Song T; Alshukairi AN; Chen R; Zhang Z; Gan M; Zhu A; Huang Y; Luo L; Mok CKP; Al Gethamy MM; Tan H; Li Z; Huang X; Li F; Sun J; Zhang Y; Wen L; Li Y; Chen Z; Zhuang Z; Zhuo J; Chen C; Kuang L; Wang J; Lv H; Jiang Y; Li M; Lin Y; Deng Y; Tang L; Liang J; Huang J; Perlman S; Zhong N; Zhao J; Malik Peiris JS; Li Y; Zhao J
    J Clin Invest; 2020 Oct; 130(10):5235-5244. PubMed ID: 32634129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study.
    Masiá M; Fernández-González M; Padilla S; Ortega P; García JA; Agulló V; García-Abellán J; Telenti G; Guillén L; Gutiérrez F
    EBioMedicine; 2020 Oct; 60():102999. PubMed ID: 32950003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia.
    Wang C; Li Y; Kaplonek P; Gentili M; Fischinger S; Bowman KA; Sade-Feldman M; Kays KR; Regan J; Flynn JP; Goldberg MB; Hacohen N; Filbin MR; Lauffenburger DA; Alter G; Li JZ
    mBio; 2022 Aug; 13(4):e0157722. PubMed ID: 35762593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity.
    Steiner S; Schwarz T; Corman VM; Gebert L; Kleinschmidt MC; Wald A; Gläser S; Kruse JM; Zickler D; Peric A; Meisel C; Meyer T; Staudacher OL; Wittke K; Kedor C; Bauer S; Besher NA; Kalus U; Pruß A; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2022; 13():840126. PubMed ID: 35359967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 clearance after breakthrough infection correlates with fit and happy T cells.
    Veldhoen M; Bertoletti A
    Immunol Cell Biol; 2023 Aug; 101(7):587-589. PubMed ID: 37212205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of capillary blood self-collection using the Tasso-SST device with venous phlebotomy for anti-SARS-CoV-2 antibody measurement.
    King ER; Garrett HE; Abernathy H; Cassidy CA; Cabell CR; Shook-Sa BE; Juliano JJ; Boyce RM; Aiello AE; Ciccone EJ
    J Immunol Methods; 2023 Sep; 520():113523. PubMed ID: 37423588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses.
    Lin Y; Zhu J; Liu Z; Li C; Guo Y; Wang Y; Chen K
    Front Immunol; 2022; 13():864278. PubMed ID: 35990623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
    Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
    Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Shojaei M; Shamshirian A; Monkman J; Grice L; Tran M; Tan CW; Teo SM; Rodrigues Rossi G; McCulloch TR; Nalos M; Raei M; Razavi A; Ghasemian R; Gheibi M; Roozbeh F; Sly PD; Spann KM; Chew KY; Zhu Y; Xia Y; Wells TJ; Senegaglia AC; Kuniyoshi CL; Franck CL; Dos Santos AFR; de Noronha L; Motamen S; Valadan R; Amjadi O; Gogna R; Madan E; Alizadeh-Navaei R; Lamperti L; Zuñiga F; Nova-Lamperti E; Labarca G; Knippenberg B; Herwanto V; Wang Y; Phu A; Chew T; Kwan T; Kim K; Teoh S; Pelaia TM; Kuan WS; Jee Y; Iredell J; O'Byrne K; Fraser JF; Davis MJ; Belz GT; Warkiani ME; Gallo CS; Souza-Fonseca-Guimaraes F; Nguyen Q; Mclean A; Kulasinghe A; Short KR; Tang B
    Front Immunol; 2022; 13():1060438. PubMed ID: 36685600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
    Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
    Front Immunol; 2021; 12():684014. PubMed ID: 34194438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.